Lanxess (ETR:LXS) received a €74.00 ($86.05) price target from equities research analysts at BNP Paribas in a research note issued to investors on Tuesday, October 2nd. The brokerage presently has a “neutral” rating on the stock. BNP Paribas’ target price points to a potential upside of 38.94% from the company’s current price.
A number of other research firms have also recently weighed in on LXS. Deutsche Bank set a €68.00 ($79.07) price objective on Lanxess and gave the company a “neutral” rating in a research report on Friday, June 15th. Nord/LB set a €74.00 ($86.05) price target on Lanxess and gave the stock a “neutral” rating in a report on Wednesday, August 8th. Baader Bank set a €65.00 ($75.58) price target on Lanxess and gave the stock a “sell” rating in a report on Wednesday, August 8th. Warburg Research set a €84.00 ($97.67) price target on Lanxess and gave the stock a “buy” rating in a report on Monday, June 18th. Finally, Jefferies Financial Group set a €69.00 ($80.23) price objective on Lanxess and gave the stock a “neutral” rating in a research note on Thursday, August 9th. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and ten have assigned a buy rating to the company. Lanxess has an average rating of “Hold” and an average price target of €73.73 ($85.73).
ETR:LXS traded up €0.28 ($0.33) on Tuesday, hitting €53.26 ($61.93). The stock had a trading volume of 481,305 shares, compared to its average volume of 312,027. Lanxess has a 52-week low of €59.89 ($69.64) and a 52-week high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Featured Story: Discover Your Risk Tolerance
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.